Press "Enter" to skip to content

GSK’s HIV drug wins European panel thumbs-up

GlaxoSmithKline Plc’s two-drug treatment for HIV infections won marketing approval from a European Medicines Agency (EMA) panel on Friday, after the British drugmaker received a nod from the U.S. Food and Drug Administration earlier this month.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/THdJNdJp0Oc/gsks-hiv-drug-wins-european-panel-thumbs-up-idINKCN1S21RB

Also Read:   Trump says he is holding big Pharma accountable in opioid fight